FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3174493129> ?p ?o ?g. }

• W3174493129 endingPage "626" @default.
• W3174493129 startingPage "614" @default.
• W3174493129 abstract "Biomarkers of fibrosis are associated with outcome in several cardiovascular diseases. However, their relevance to chronic kidney disease and dialysis is uncertain, as it remains unclear how the kidneys and the dialysis procedure itself affect their elimination and degradation. We aimed to investigate the relationship of the blood levels of two markers associated with fibrosis: procollagen type I C-terminal pro-peptide (PICP) and galectin-3 (Gal-3) with mortality in dialysis patients.Procollagen type I C-terminal pro-peptide and galectin-3 were measured at baseline in 2773 patients enrolled in the AURORA trial, investigating the effect of rosuvastatin on cardiovascular outcomes, in patients on hemodialysis, and their interaction with CV death or all-cause mortality using survival models. The added prognostic value of these biomarkers was assessed by the net reclassification improvement (NRI).The median follow-up period was 3.8 years. Blood concentrations of PICP and Gal-3 were significantly associated with CV death [adjusted HR per 1 SD = 1.11 (1.02-1.20) and SD = 1.20 (1.10-1.31), respectively] and all-cause mortality (all adjusted p < 0.001). PICP and Gal-3 had a synergistic effect with regard to CV death and all-cause mortality (interaction p = 0.04 and 0.01, respectively). Adding PICP, Gal-3 and their interaction on top of clinical and biological covariates, resulted in significantly improved prognostic accuracy NRI = 0.080 (0.019-0.143) for CV death.In dialysis patients, concomitant increase in PICP and Gal-3 concentrations are associated with higher rates of CV death. These results suggest that concomitantly raised PICP and Gal-3 may reflect an activated fibrogenesis relevant to risk stratification in dialysis, raising the hypothesis that anti-fibrotic therapy may be beneficial for cardiovascular protection in such patients." @default.
• W3174493129 created "2021-07-05" @default.
• W3174493129 creator A5000046286 @default.
• W3174493129 creator A5008530481 @default.
• W3174493129 creator A5013453825 @default.
• W3174493129 creator A5019505273 @default.
• W3174493129 creator A5026753394 @default.
• W3174493129 creator A5027358718 @default.
• W3174493129 creator A5036821495 @default.
• W3174493129 creator A5040557338 @default.
• W3174493129 creator A5049235067 @default.
• W3174493129 creator A5052855323 @default.
• W3174493129 creator A5071642919 @default.
• W3174493129 creator A5071660720 @default.
• W3174493129 creator A5081791142 @default.
• W3174493129 creator A5088849387 @default.
• W3174493129 creator A5089724634 @default.
• W3174493129 date "2021-06-25" @default.
• W3174493129 modified "2023-10-14" @default.
• W3174493129 title "Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial" @default.
• W3174493129 cites W1508664133 @default.
• W3174493129 cites W1929982114 @default.
• W3174493129 cites W1957009538 @default.
• W3174493129 cites W1971604855 @default.
• W3174493129 cites W1981384991 @default.
• W3174493129 cites W1992700728 @default.
• W3174493129 cites W1994872585 @default.
• W3174493129 cites W2014289302 @default.
• W3174493129 cites W2015404118 @default.
• W3174493129 cites W2023634166 @default.
• W3174493129 cites W2032576629 @default.
• W3174493129 cites W2033360508 @default.
• W3174493129 cites W2035427613 @default.
• W3174493129 cites W2043586033 @default.
• W3174493129 cites W2048178709 @default.
• W3174493129 cites W2079811833 @default.
• W3174493129 cites W2085843424 @default.
• W3174493129 cites W2093884277 @default.
• W3174493129 cites W2097058099 @default.
• W3174493129 cites W2102815431 @default.
• W3174493129 cites W2103509213 @default.
• W3174493129 cites W2104653782 @default.
• W3174493129 cites W2105660160 @default.
• W3174493129 cites W2108113751 @default.
• W3174493129 cites W2119340816 @default.
• W3174493129 cites W2122295539 @default.
• W3174493129 cites W2124405902 @default.
• W3174493129 cites W2135164569 @default.
• W3174493129 cites W2135350140 @default.
• W3174493129 cites W2140713776 @default.
• W3174493129 cites W2142280282 @default.
• W3174493129 cites W2143795945 @default.
• W3174493129 cites W2159554935 @default.
• W3174493129 cites W2162430779 @default.
• W3174493129 cites W2162672583 @default.
• W3174493129 cites W2166805849 @default.
• W3174493129 cites W2171981556 @default.
• W3174493129 cites W2244960457 @default.
• W3174493129 cites W2261531186 @default.
• W3174493129 cites W2268786000 @default.
• W3174493129 cites W2409342597 @default.
• W3174493129 cites W2411016206 @default.
• W3174493129 cites W2436941773 @default.
• W3174493129 cites W2509272523 @default.
• W3174493129 cites W2568658144 @default.
• W3174493129 cites W2598019630 @default.
• W3174493129 cites W2776273511 @default.
• W3174493129 cites W2790476536 @default.
• W3174493129 cites W2805580384 @default.
• W3174493129 cites W2807253610 @default.
• W3174493129 cites W2889168093 @default.
• W3174493129 cites W2891594773 @default.
• W3174493129 cites W2895377702 @default.
• W3174493129 cites W2899004553 @default.
• W3174493129 cites W2909087359 @default.
• W3174493129 cites W2910662478 @default.
• W3174493129 cites W2911937084 @default.
• W3174493129 cites W2912308947 @default.
• W3174493129 cites W2925041288 @default.
• W3174493129 cites W2926516028 @default.
• W3174493129 cites W2943197097 @default.
• W3174493129 cites W2944050376 @default.
• W3174493129 cites W3000164989 @default.
• W3174493129 cites W4211082352 @default.
• W3174493129 cites W604783079 @default.
• W3174493129 doi "https://doi.org/10.1007/s00392-021-01898-9" @default.
• W3174493129 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34170371" @default.
• W3174493129 hasPublicationYear "2021" @default.
• W3174493129 type Work @default.
• W3174493129 sameAs 3174493129 @default.
• W3174493129 citedByCount "5" @default.
• W3174493129 countsByYear W31744931292021 @default.
• W3174493129 countsByYear W31744931292023 @default.
• W3174493129 crossrefType "journal-article" @default.
• W3174493129 hasAuthorship W3174493129A5000046286 @default.
• W3174493129 hasAuthorship W3174493129A5008530481 @default.
• W3174493129 hasAuthorship W3174493129A5013453825 @default.
• W3174493129 hasAuthorship W3174493129A5019505273 @default.

• next